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Introduction 
Milk represents one of the most important dietary sources of nutrients for 
humans due to its rich nutritional composition. However, milk 
consumption is also potentially related to the ingestion of chemical 
contaminants such as mycotoxins.  Aflatoxin B1 (AFB1) is a highly toxic 
mycotoxin, for both animals and humans. This toxin is frequently detected 
in milk, and it results from the ingestion of contaminated feed by 
producing animals. Given its high toxicity, methods of AFB1 
decontamination, including the use of probiotic microorganisms, have 
been tested in milk. But the total amount of ingested contaminant does 
not always reflect the amount available for absorption (bioavailability), so 
in vitro digestion models are used to determine human oral bioavailability 
of food contaminants. Regarding prebiotics, few studies have evaluated 
the decontamination of action of these compounds and it is suggested 
further that the probiotics to be synergistic in the removal of mycotoxins.  
Objective 
Materials and methods 
Milk samples spiked with AFB1 (10 μg.L-1) were inoculated with L. 
plantarum and with the prebiotic compounds inulin, beta-glucan, 
polydextrose and oligofructose, isolated and combined, in a total of 12 
different assays plus two controls (Table 1). The samples were subjected 
to in vitro digestibility (Figure 1). AFB1 was quantified in samples by 
UHPLC-FLD before and after digestion.  
The study aimed to evaluate the effect of the probiotic microorganism 
Lactobacillus plantarum BG112 and of several prebiotics (inulin, beta-
glucan, polydextrose and oligofructose), alone or combined, in the 
bioavailability of AFB1 in milk artificially contaminated with the mycotoxin, 
after digestibility in an in vitro digestion model.  
Conclusions 
 
 Bioavailability of AFB1 was reduced by the addition of L. plantarum and 
prebiotics under all tested conditions.  
 L. plantarum can be incorporated into a food matrix in order to reduce 
the bioavailability of AFB1. 
 The results help explain how some natural components present in food 
can help modulate the intake of certain toxic compounds. 
 
Table 1 - Matrix planning Plackett Burman of 12 trials 
with 02 central points. 
 
a AFB1 concentration (ug.L-1);  
b Time (h);  
c Inulin;  
d Oligofructose;  
e B-Glucan;  
 f Polydextrose  
• Positive control;  
• ** Negative control 
 
Levels:  
[AFB1]: +1 / 0 / -1 = 10 / 7.5 / 5 
Time: +1/ 0 / -1 = 6h, 3h, 0h;  
% Prebiotics: +1/0/-1 = 0.75/0.38/0 
Results and Discussion 
 The bioavailability of AFB1 on milk obtained for the various probiotic and 
prebiotics combinations after in vitro digestion ranged from 15.6 to 35.6% of the 
spiked amount. 
 The addition of L. plantarum BG112 alone on AFB1 contaminated milk resulted on 
AFB1 bioavailability of 27.1 ± 0.93%, a level similar to that reported by other 
authors, emphasizing the binding capacity of the acid lactic bacteria with AFB1.  
 Concerning prebiotics effect, bioavailability of AFB1 varied between 15 and 51%. 
The best result was observed for prebiotics inulin and oligofructose when tested 
individually. 
Table 2 – Bioavailability of AFB1 after in vitro digestion with 
the various probiotic and prebiotics combinations. 
Figure 1 – Scheme of in vitro digestion and 
detection and quantification of available AFB1 
after the various treatments 
 
Figure 2 - Chromatograms of milk samples fortified with AFB1, after in vitro digestion: a) without 
detectable AFB1; b) with AFB1. 
a b 
